Measurements, Mean (SD)/N (%) | Overall | ARIC | CHS | MESA | HABC |
---|---|---|---|---|---|
Population | (N = 24,732) | (N = 13,137) | (N = 4850) | (N = 4486) | (N = 2259) |
Event counts | 357 (1.5%) | 139 (1.1%) | 77 (1.5%) | 104 (2.2%) | 37 (1.7%) |
Follow-up time, Median [IQR] | 8.97 [6.85, 10.28] | 9.11 [8.77, 23.34] | 8.80 [5.92, 8.95] | 9.40 [9.14, 9.73] | 3.01 [2.95, 3.10] |
Age at baseline, yr | 60.5 (10.3) | 54.0 (5.72) | 72.1 (5.51) | 60.3 (9.57) | 73.5 (2.84) |
Gender | Â | Â | Â | Â | Â |
 Female | 14,067 (56.9%) | 7433 (56.6%) | 2950 (60.8%) | 2398 (53.5%) | 1286 (56.9%) |
 Male | 10,665 (43.1%) | 5704 (43.4%) | 1900 (39.2%) | 2088 (46.5%) | 973 (43.1%) |
Race | Â | Â | Â | Â | Â |
 Black | 6134 (24.8%) | 3256 (24.8%) | 768 (15.8%) | 1192 (26.6%) | 918 (40.6%) |
 White | 17,075 (69.0%) | 9881 (75.2%) | 4050 (83.5%) | 1803 (40.2%) | 1341 (59.4%) |
 Other | 1523 (6.2%) | 0 (0%) | 32 (0.7%) | 1491 (33.2%) | 0 (0%) |
Smoking status | Â | Â | Â | Â | Â |
 Current | 4635 (18.7%) | 3281 (25.0%) | 589 (12.1%) | 554 (12.3%) | 211 (9.3%) |
 Former | 8751 (35.4%) | 4183 (31.8%) | 1937 (39.9%) | 1646 (36.7%) | 985 (43.6%) |
 Never | 11,346 (45.9%) | 5673 (43.2%) | 2324 (47.9%) | 2286 (51.0%) | 1063 (47.1%) |
BMI | 27.5 (5.09) | 27.6 (5.30) | 26.6 (4.10) | 28.3 (5.37) | 27.4 (4.80) |
Fasting glucose (mg/dL), Median [IQR] | 97.3 [90.0, 106.9] | 99.0 [93.0, 107.0] | 101.0 [94.0, 111.0] | 89.0 [82.0, 98.0] | 94.0 [87.0, 104.0] |
Systolic blood pressure (mmHg) | 126 (20.8) | 121 (18.3) | 140 (20.6) | 125 (20.4) | 135 (20.5) |
Diastolic blood pressure (mmHg) | 72.6 (11.1) | 73.6 (11.0) | 71.0 (11.5) | 71.9 (10.1) | 71.3 (11.6) |
LDL (mg/dL) | 131 (37.4) | 137 (39.1) | 130 (35.4) | 117 (31.3) | 123 (33.7) |
HDL (mg/dL) | 52.8 (16.5) | 52.1 (17.0) | 55.2 (15.7) | 51.2 (14.9) | 55.1 (16.8) |
Medication use | Â | Â | Â | Â | Â |
 Antihypertensive medication | 8178 (33.1%) | 3415 (26.0%) | 2106 (43.4%) | 1523 (34.0%) | 1134 (50.2%) |
 Lipid-lowering drugs | 1332 (5.4%) | 148 (1.1%) | 221 (4.6%) | 716 (16.0%) | 247 (10.9%) |
 Oral Antidiabetics | 1118 (4.5%) | 371 (2.8%) | 259 (5.3%) | 329 (7.3%) | 159 (7.0%) |
 Insulin | 480 (1.9%) | 233 (1.8%) | 97 (2.0%) | 64 (1.4%) | 86 (3.8%) |